ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTC/BB: SNWV) (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported the results of published preclinical osteoarthritis research conducted in Taiwan utilizing extracorporeal shock wave technology (ESWT) to prevent and repair osteoarthritis damage. The study, entitled “Extracorporeal Shockwave Therapy Shows Chondroprotective Effects in Osteoarthritic Rat Knee,” by Wang, C.J. et al., is available in the online edition of Archives of Orthopedic Trauma Surgery as an ePublication ahead of print.
